Trial intelligence / Profile preview

Local Tranexamic Acid Injection for Surgical Field Improvement During FESS in Chronic Rhinosinusitis

TCTR20210531005Phase 4Not yet recruiting

Sponsor
N/A
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in chronic rhinosinusitis (CRS) (2 arms), sponsored by N/A. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on TCTR20210531005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210531005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call